1. Home
  2. VERA vs FRME Comparison

VERA vs FRME Comparison

Compare VERA & FRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERA
  • FRME
  • Stock Information
  • Founded
  • VERA 2016
  • FRME 1893
  • Country
  • VERA United States
  • FRME United States
  • Employees
  • VERA N/A
  • FRME N/A
  • Industry
  • VERA Biotechnology: Pharmaceutical Preparations
  • FRME Major Banks
  • Sector
  • VERA Health Care
  • FRME Finance
  • Exchange
  • VERA Nasdaq
  • FRME Nasdaq
  • Market Cap
  • VERA 2.5B
  • FRME 2.1B
  • IPO Year
  • VERA 2021
  • FRME N/A
  • Fundamental
  • Price
  • VERA $42.01
  • FRME $37.96
  • Analyst Decision
  • VERA Strong Buy
  • FRME Buy
  • Analyst Count
  • VERA 9
  • FRME 5
  • Target Price
  • VERA $53.56
  • FRME $43.90
  • AVG Volume (30 Days)
  • VERA 683.6K
  • FRME 248.8K
  • Earning Date
  • VERA 11-07-2024
  • FRME 10-24-2024
  • Dividend Yield
  • VERA N/A
  • FRME 3.78%
  • EPS Growth
  • VERA N/A
  • FRME N/A
  • EPS
  • VERA N/A
  • FRME 3.01
  • Revenue
  • VERA N/A
  • FRME $593,089,000.00
  • Revenue This Year
  • VERA N/A
  • FRME N/A
  • Revenue Next Year
  • VERA N/A
  • FRME $3.02
  • P/E Ratio
  • VERA N/A
  • FRME $12.35
  • Revenue Growth
  • VERA N/A
  • FRME N/A
  • 52 Week Low
  • VERA $9.68
  • FRME $26.85
  • 52 Week High
  • VERA $50.78
  • FRME $42.45
  • Technical
  • Relative Strength Index (RSI)
  • VERA 52.57
  • FRME 53.37
  • Support Level
  • VERA $39.22
  • FRME $35.13
  • Resistance Level
  • VERA $50.00
  • FRME $37.35
  • Average True Range (ATR)
  • VERA 2.41
  • FRME 1.17
  • MACD
  • VERA 0.24
  • FRME -0.06
  • Stochastic Oscillator
  • VERA 28.53
  • FRME 54.14

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About FRME First Merchants Corporation

First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.

Share on Social Networks: